Crizotinib is an oral small-molecule multi-target tyrosine kinase inhibitor, and the world’s first approved targeted antineoplastic agent for both ALK and ROS1. Its common dosage form is capsules.
Authentic
Guarantee
Fast Delivery
Privacy Crizotinib has a proven therapeutic effect on ALK-related diseases, effectively controlling tumor progression and improving patient clinical outcomes.···【More】
Update: 24 Mar,2026Source: BigbearViews: 95
Crizotinib may cause side effects that do not require medical intervention and may gradually disappear as the body adapts to the drug during treatment···【More】
Update: 24 Mar,2026Source: BigbearViews: 93
Crizotinib has different specific usages in adults and children for different indications. Users are advised to consult their doctor before using criz···【More】
Update: 24 Mar,2026Source: BigbearViews: 99
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



